Abbasi-Kangevari M, Mohebi F, Ghamari S-H, Modirian M, Shahbal N, Ahmadi N, Farzi Y, Azmin M, Roshani S, Zokaei H. Quality and cost of healthcare services in patients with diabetes in iran: results of a nationwide short-term longitudinal survey. Front Endocrinol. 2023;14:1099464.
Mansoori A, Sahranavard T, Hosseini ZS, Soflaei SS, Emrani N, Nazar E, Gharizadeh M, Khorasanchi Z, Effati S, Ghamsary M. Prediction of type 2 diabetes mellitus using hematological factors based on machine learning approaches: a cohort study analysis. Sci Rep. 2023;13(1):663.
Google Scholar
DeFronzo RA. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773–95.
Google Scholar
Mekala KC, Bertoni AG. Epidemiology of diabetes mellitus. Transplantation, bioengineering, and regeneration of the endocrine pancreas. edn.: Elsevier; 2020. pp. 49–58.
National Diabetes Statistics Report. [https://www.cdc.gov/diabetes/data/statistics-report]
Duan M-J, Dekker LH, Carrero J-J, Navis G. Lifestyle patterns and incident type 2 diabetes in the Dutch lifelines cohort study. Prev Med Rep. 2022;30:102012.
Google Scholar
Moradpour F, Rezaei S, Piroozi B, Moradi G, Moradi Y, Piri N, Shokri A. Prevalence of prediabetes, diabetes, diabetes awareness, treatment, and its socioeconomic inequality in West of Iran. Sci Rep. 2022;12(1):17892.
Google Scholar
Mirzaei M, Rahmaninan M, Mirzaei M, Nadjarzadeh A, Dehghani Tafti AA. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in central iran: results from Yazd health study. BMC Public Health. 2020;20(1):166.
Google Scholar
Gundogan K, Bayram F, Gedik V, Kaya A, Karaman A, Demir Ö, Sabuncu T, Kocer D, Coskun R. Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults. Archives Med Sci. 2013;9(2):243–53.
Google Scholar
Type. 2 Diabetes [https://idf.org/about-diabetes/type-2-diabetes/]
About Type 2 Diabetes. [https://www.cdc.gov/diabetes/about/about-type-2-diabetes.html]
Harati H, Hadaegh F, Saadat N, Azizi F. Population-based incidence of type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health. 2009;9:1–8.
Nylund-Gibson K, Choi AY. Ten frequently asked questions about latent class analysis. Translational Issues Psychol Sci. 2018;4(4):440.
Weller BE, Bowen NK, Faubert SJ. Latent class analysis: a guide to best practice. J Black Psychol. 2020;46(4):287–311.
Moftakhar L, Rezaeianzadeh R, Ghoddusi Johari M, Hosseini SV, Rezaianzadeh A. Epidemiology and predictors of Multimorbidity in Kharameh cohort study: A population-based cross‐sectional study in Southern Iran. Health Sci Rep. 2023;6(1):e988.
Google Scholar
Wu Y, Hu H, Cai J, Chen R, Zuo X, Cheng H, Yan D. Applying latent class analysis to risk stratification of incident diabetes among Chinese adults. Diabetes Res Clin Pract. 2021;174:108742.
Google Scholar
Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A-A, Hekmatdoost A, Mohammadi Z, Mahmoudi Z, Shayanrad A, Roozafzai F, et al. Prospective epidemiological research studies in Iran (the PERSIAN cohort Study): Rationale, Objectives, and Design. Am J Epidemiol. 2017;187(4):647–55.
Google Scholar
Saugel B, Dueck R, Wagner JY. Measurement of blood pressure. Best Pract Res Clin Anaesthesiol. 2014;28(4):309–22.
Google Scholar
Ghosh A, Halder D, Mukhopadhyay K. Comparative assessment of blood pressure, random blood sugar and addiction status among security staffs and scavengers in an Indian medical college hospital. Int J Curr Microbiol App Sci. 2016;5(10):294–300.
Tayefi M, Shabani N, Saberi-Karimian M, Oladi M, Mouhebati M, Farjami Z, Hoseini ZS, Mohammadi-Bajgyran M, Mahmoudi AA, Doustabad ME. Systolic and diastolic blood pressure percentiles by age and gender in Northeastern Iran. J Am Soc Hypertens. 2018;12(12):e85–91.
Google Scholar
Fan W, Philip S, Granowitz C, Toth PP, Wong ND. Prevalence of US adults with triglycerides ≥ 150 mg/dl: NHANES 2007–2014. Cardiol Ther. 2020;9(1):207–13.
Google Scholar
Ford ES. Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the US. Diabetes Care. 2005;28(11):2745–9.
Google Scholar
Le VT, Anderson JL, Calderone P, Perez AC, Knight S, May HT, Horne BD, Muhlestein JB, Knowlton KU. Analysis of 10-yr MACE risk of LDL-C ≥ 160–189 mg/dl compared to < 160 mg/dl in young adults (ages 20–39) in an integrated healthcare system. Circulation. 2021;144(Suppl1):A11605–11605.
Virani SS, Ballantyne CM. Low-Density Lipoprotein Cholesterol: Is 160 the New 190? Circulation 2018, 138(21):2326–2329.
LDL. The Bad Cholesterol [https://medlineplus.gov/ldlthebadcholesterol.html]
Roth GA, Fihn SD, Mokdad AH, Aekplakorn W, Hasegawa T, Lim SS. High total serum cholesterol, medication coverage and therapeutic control: an analysis of National health examination survey data from eight countries. Bull World Health Organ. 2011;89:92–101.
Google Scholar
BMI categories for adults. [https://www.cdc.gov/bmi/adult-calculator/bmi-categories.html]
Nikbakht H-A, Rezaianzadeh A, Seif M, Shojaie L, Johari MG, Ghaem H. Physical activity and metabolic syndrome: A population base study (forest and tree model algorithms). Clin Nutr ESPEN. 2023;56:173–9.
Google Scholar
poLCA. An R Package for Polytmous variable Latent Class Analysis. [R Package]. [https://CRAN.R-project.org/package=poLCA]
Shrestha B, Nepal B, Shakya YL, Regmi B. Life style factors associated with the risk of type 2 diabetes mellitus. Grande Med J. 2019;1(2):77–83.
Farhadnejad H, Teymoori F, Asghari G, Mokhtari E, Mirmiran P, Azizi F. The higher adherence to a healthy lifestyle score is associated with a decreased risk of type 2 diabetes in Iranian adults. BMC Endocr Disorders. 2022;22(1):42.
Google Scholar
Department HS. Let’s make the next generation tobacco-free: your guide to the 50th anniversary surgeon general’s report on smoking and health. Government Printing Office; 2014.
Suter PM, Tremblay A. Is alcohol consumption a risk factor for weight gain and obesity? Crit Rev Clin Lab Sci. 2005;42(3):197–227.
Google Scholar
IKEDA I, FUJIHARA K, TAKEDA Y, HORIKAWA C, FERREIRA KODAMAS, MORI ED, KADOWAKI Y, YAMAMOTO-HONDA R T, ARASE Y. 1666-P: effect of obesity in family history (FH) on the prevalence of type 2 diabetes mellitus (T2DM), hypertension (HT), and dyslipidemia (DL). Diabetes 2024, 73(Supplement_1).
Pasdar Y, Rezaeian S, Mohammadi E, Khosravi shadmani F, Shahnazi N, Najafi F, Nazar MM, Darbandi M. The interaction between general or abdominal obesity and hypertension on the risk of type 2 diabetes mellitus: a cross-sectional analysis in Iranian adults from the RaNCD cohort study. BMC Public Health. 2024;24(1):752.
Google Scholar
Suputra IGLRD, Budiyasa DGA. Faktor Risiko Kejadian diabetes melitus Tipe 2 Pada Pasien Rawat Jalan Di RSUD Sanjiwani Gianyar. Herb-Medicine Journal: Terbitan Berkala Ilmiah Herb Kedokteran Dan Kesehatan. 2023;5(4):23–7.
Engwa GA, Okolie A, Nwalo FN, Akaniro-Ejim E, Unachukwu MN, Ozofor MN, Agbafor KN, Ubi BE. Association of obesity and dyslipidaemia with type 2 diabetes in outpatients of Enugu state university teaching hospital (ESUTH) in Enugu Nigeria. J Life Sci. 2018;12:92–9.
Liang T, Xu D, Yao B. 2251-PUB: relationship between type 2 diabetes and dyslipidemia in adult residents of Minhang district, shanghai: A multistage, stratified cluster sampling survey. Diabetes 2019, 68(Supplement_1).
Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, Roverato A, Guaraldi G, Lonardo A. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31(5):936–44.
Google Scholar
Morrison AE, Zaccardi F, Khunti K, Davies MJ. Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta‐analysis with bias analysis. Liver Int. 2019;39(3):557–67.
Google Scholar
Zaccardi F, Pitocco D, Martini F, Caputo S, Miele L, Grieco A, Ghirlanda G. A case of esomeprazole-induced transient diabetes and hepatitis: the role of liver inflammation in the pathogenesis of insulin resistance. Acta Diabetol. 2014;51:151–3.
Google Scholar
Nasr P, Fredrikson M, Ekstedt M, Kechagias S. The amount of liver fat predicts mortality and development of type 2 diabetes in non-alcoholic fatty liver disease. Liver Int. 2020;40(5):1069–78.
Google Scholar
Kautzky-Willer A, Leutner M, Harreiter J. Sex differences in type 2 diabetes. Diabetologia. 2023;66(6):986–1002.
Google Scholar
Barbier JM, Amiguet M, Vaucher J, Lasserre AM, Clair C, Schwarz J. Exploring the gender difference in type 2 diabetes incidence in a Swiss cohort using latent class analysis: an intersectional approach. BMJ Public Health 2024, 2(1).
Olayeye TO, Bodunwa OK, Adewole AI, PREVALENCE AND RISK FACTORS OF DIABETES MELLITUS AMONG WOMEN USING THE MULTINOMIAL LOGISTIC REGRESSION MODEL. FUDMA J Sci. 2024;8(1):195–200.
Li Y. Research on the influencing factors that affecting female diabetes. Highlights Sci Eng Technol. 2024;91:304–9.
Cassidy FC, Lafferty S, Coleman CM. The role of gender in the onset, development and impact of type 2 diabetes mellitus and its co-morbidities. Type 2 Diabetes-From pathophysiology to cyber systems. edn.: IntechOpen; 2020.
Liu Ying LY, Wang KeSheng WK, Maisonet M, Wang Liang WL, Zheng ShiMin ZS. Associations of lifestyle factors (smoking, alcohol consumption, diet and physical activity) with type 2 diabetes among American adults from National health and. Nutrition Examination Survey (NHANES; 2017. pp. 2005–14.
Masuda H, Ishiyama D, Yamada M, Iwashima F, Kimura Y, Otobe Y, Tani N, Suzuki M, Nakajima H. Relationship between long-term objectively measured physical activity and glycemic control in type 2 diabetes mellitus patients: a prospective cohort study. Diabetes Metabolic Syndrome Obes 2021:2057–63.
Pai L-W, Li T-C, Hwu Y-J, Chang S-C, Chen L-L, Chang P-Y. The effectiveness of regular leisure-time physical activities on long-term glycemic control in people with type 2 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2016;113:77–85.
Google Scholar
Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001;286(10):1218–27.
Google Scholar
Boniol M, Dragomir M, Autier P, Boyle P. Physical activity and change in fasting glucose and HbA1c: a quantitative meta-analysis of randomized trials. Acta Diabetol. 2017;54:983–91.
Google Scholar
Umpierre D, Ribeiro PA, Kramer CK, Leitao CB, Zucatti AT, Azevedo MJ, Gross JL, Ribeiro JP, Schaan BD. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2011;305(17):1790–9.
Google Scholar
Amanat S, Ghahri S, Dianatinasab A, Fararouei M, Dianatinasab M. Exercise and type 2 diabetes. Phys Exerc Hum Health 2020:91–105.
Bassin SR, Srinath R. The impact of physical activity in patients with type 2 diabetes. Am J Lifestyle Med. 2025;19(1):147–61.
Google Scholar